Meteoric iron, diluted until a daily dose holds less iron than one red blood cell, sold as sugar pellets, tablets, and injections for feverish illness, slow recovery, exhaustion, and low mood. No controlled trial has tested the preparation itself. Direct harm is small; the larger cost is a treatable cause of exhaustion left unexamined. Claims rest on tradition, not measurement. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Ferritin | 50–100 ng/mL (women), 70–150 ng/mL (men) | Iron stores; the commonest treatable cause of the fatigue this product targets |
| Transferrin saturation | 25–40% | Separates true iron deficiency from inflammation-driven low iron |
| Haemoglobin and MCV | Haemoglobin 13.5–15.0 g/dL (women), 14.0–16.0 g/dL (men); MCV 85–92 fL | Detects anaemia and points to its type before symptoms are self-treated |
| TSH | 0.5–2.0 mIU/L | An underactive thyroid is a classic cause of exhaustion and low drive |
| C-reactive protein (high-sensitivity) | Below 1.0 mg/L | Flags inflammation or ongoing infection driving the symptoms |
| Vitamin B12 | 500–900 pg/mL | Deficiency mimics the exhaustion and low mood claimed as indications |
| 25-hydroxyvitamin D | 40–60 ng/mL | Low status tracks fatigue and low mood in the same symptom cluster |
| Response to the preparation itself | No established target exists; track change from the person's own baseline on a fatigue score | Would otherwise show whether the preparation is doing anything |
Cadence: Baseline, fasting and in the morning, before use; symptom review at 2 weeks; repeat blood testing at 3 months only if symptoms persist; routine annual testing thereafter. Any red-flag symptom moves assessment forward immediately rather than waiting for the next scheduled timepoint.